Journal of investigational allergology & clinical immunology
Omalizumab as Premedication for Hypersensitivity Reactions Refractory to Asparaginase Desensitization in Children With Acute Lymphoblastic Leukemia.
Teodorikez-Wilfox Jimenez-Rodriguez, Angela Rico Rodes, Amparo Burgos San Jose, María Del Cañizo Moreira, Laura Ureña Horno, Maria E Valerio Alonso, Andrea Cano Rodriguez, Clara P Gallego Velez, María P González Delgado, María Tasso Cereceda
Published: 202510.18176/jiaci.1118
No abstract available for this study.